From preclinical to clinical: Making drug development efficient thru community-based collaboration

A Fragile-X Syndrome Case Study Panel Discussion hosted by the Rare Advocacy Movement's Collaboration Zone at the 5th Pharma Pricing, Reimbursement & Market Access 2021 Conference.

Moderator:
Nadia Bodkin of the Rare Advocacy Movement (RAM)

Panelists:
1. Katie Clapp of the FRAXA Research Foundation
2. Michael Tranfaglia of the FRAXA Research Foundation
3. Christopher U. Missling of Anavex Life Sciences

#FragileXFXSFRAXA